Home›Companies›Biotech & Pharma›Swan NeuroTech

Swan NeuroTech, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 2, 2024·Suggest an edit

About Swan NeuroTech

Swan NeuroTech is a private company based in Canonsburg, Pennsylvania. It has reported $175,000 raised in two offerings on Form D since March 2020. Its chief executive is Jeremy Kimmel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 18, 2024Apr 2, 2024$95,000target not set7$13,571DebtRule 506(b)Form D ↗
Mar 17, 2020Mar 26, 2020$80,000of $200K target5$16,000Debt, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$175,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Swan NeuroTech's Form D filed Apr 2, 2024.

JK
Jeremy Kimmel
Chief Executive Officer
KM
Kacey Marra
Director

Earlier filings also listed Tony Windebank (director, last listed Mar 2020), Steve Winowich (director, last listed Mar 2020), Kia Washington (director, last listed Mar 2020), David Smith (secretary, last listed Mar 2020), Ben Schilling (executive officer, last listed Mar 2020) and Arta Kelmendi-Doko (director, last listed Mar 2020).

Sources

  1. SECSwan NeuroTech, Inc. filing history